What is Glioblastoma?

Glioblastoma is a fast-growing and aggressive brain cancer. It can invade and destroy healthy tissue, making it difficult to treat.

Traditional CAR-T Therapy

CAR-T therapy is a type of immunotherapy that reprograms a patient's immune cells to target cancer.

A New Approach: CAR-TEAM Cells

Researchers developed CAR-TEAM cells, combining CAR-T with T-cell engaging antibody molecules (TEAMs).

The Clinical Trial

A phase 1 clinical trial tested CAR-TEAM cells on three patients with recurrent glioblastoma.

Remarkable Results

All three patients experienced significant tumor reduction after a single treatment.

Positive Long-Term Effects

The treatment response in one patient was sustained for over six months.

Experts Weigh In

Dr. Bryan Choi: "This approach has the potential to be more effective against glioblastoma.

Hope for the Future

More research is needed to confirm its effectiveness and long-term benefits.

Stay Informed

Stay updated on the latest advancements in cancer research.